Chemical formula: C₂₈H₂₉F₂N₃O Molecular mass: 461.546 g/mol PubChem compound: 16362
Pimozide is an orally active neuroleptic drug which blocks central dopaminergic receptors. Pimozide antagonises many of the actions of amphetamine and apomorphine.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05AG02 | Pimozide | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AG Diphenylbutylpiperidine derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| ORAP Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Pimozide is an active ingredient of these brands:
Brazil (BR)Estonia (EE)France (FR)Germany (DE)Malta (MT)Netherlands (NL)South Africa (ZA)Spain (ES)Tunisia (TN)Turkey (TR)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
